| « Previous month | Next month » |
23-Dec-2011 - In-Pharmatechnologist.com would like to wish all our readers a happy holiday
22-Dec-2011 - The US FDA is seeking information to help it protect celiac disease patients from pharma ingredients derived from wheat, barley, or rye.
22-Dec-2011 - Pall will buy US instrument maker ForteBio next year in a continuation of efforts to build its biomanufacturing technology offering.
22-Dec-2011 - Amgen has partnered with non-branded drugmaker Watson to develop biosimilar cancer drugs in a deal that goes some way towards protecting its own portfolio from generic competition.
22-Dec-2011 - Electroporation is the wave of the future for transdermal drug delivery, according to Parexel’s Ravi Harapanhalli.
21-Dec-2011 - It’s been a busy year for API (active pharmaceutical ingredient) manufacturers with new facilities, cost pressures and regulatory developments all hitting the headlines.And it seems recent developments in HPAPIs (high...
21-Dec-2011 - Ranbaxy has signed a consent decree with the US FDA and set aside $500m for penalty payments to settle its longstanding dispute.
21-Dec-2011 - Eli Lilly is collaborating with Arecor to develop stable aqueous or higher concentration formulations of protein and peptide drugs.
21-Dec-2011 - Intracellular drug delivery testing could become quicker thanks to probes that "light up" when a medicine is delivered to a tumour.
20-Dec-2011 - DSM Biologics will work with the Australian Institute for Bioengineering and Nanotechnology (AIBN) on the commercialisation of development-stage biologics projects.
20-Dec-2011 - China will keep its position as a leading API and intermediates supplier thanks to recovering global demand and the growth of the generic sector say market analysts.
20-Dec-2011 - Eli Lilly has expanded its drug delivery partnership with Starpharma to include further in vivo studies and clinical testing.
20-Dec-2011 - Counterfeit anti-malarials containing the Viagra API were probably manufactured in Southeast Asia, researchers found.
19-Dec-2011 - BASF has raised its prices for three ethanolamines (EOA), key intermediates in the production of a wide range of active pharmaceutical ingredients (API).
19-Dec-2011 - Drug-loaded lollipops are the ideal dosage form to boost compliance in children with oral thrush, Indian researchers found.
19-Dec-2011 - in-PharmaTechnologist presents its weekly round-up of the latest appointments within the pharmaceutical industry, including news from Vertex, Pfizer and Prolong.
19-Dec-2011 - Manufacturers of certain critical drugs must report production interruptions to the FDA under a new interim final rule.
19-Dec-2011 - GE Healthcare wont say if its new turnkey biologics plant development service will offer Governments in emerging nations discounted rates.
15-Dec-2011 - Seppic has seen a boom in demand for its new natural origin coating agents for pharmaceuticals, which can speed up production time by 50 per cent at lab stage.
15-Dec-2011 - Researchers have developed a Trojan-horse-style delivery system that transports steroids to the retina for the treatment of age-related macular degeneration and retinitis pigmentosa.
15-Dec-2011 - A treaty on medicine quality is needed to fix the major public health problem of substandard drugs, according to academics.
15-Dec-2011 - AMPAC posted a fourth quarter loss as process improvement difficulties offset rising demand for CNS and oncology ingredients.
14-Dec-2011 - UK-headquartered Archimedes Pharma has licensed its Targit drug delivery tech to Sweden’s Pharmalink AB for its candidate renal failure treatment, Nefecon.
14-Dec-2011 - GE Healthcare and M+W Group aim to capture a share of the rapidly expanding global biologics market with a new plant and manufacturing tech partnership.
14-Dec-2011 - The EMA has recommended recalling a batch of Gilead’s Vistide manufactured by Ben Venue over particle contamination concerns.
13-Dec-2011 - ADC Biotechnology (ADC Bio) has secured a development grant for a new antibody drug conjugate (ADC) manufacturing technology that, it says, can make drug production cheaper.
13-Dec-2011 - The FDA and the EMA will begin sharing facility inspection data in their respective territories from January to make better use of resources and reduce drugmakers’ inspection burdens.
13-Dec-2011 - Hospira says Chairman Christopher Begley’s impending retirement is unrelated to quality problems at manufacturing plant or recent investor criticism.
13-Dec-2011 - Scientists believe they have developed one-stop gene therapy that could almost eradicate haemophilia.
12-Dec-2011 - Chemicals firm Vertellus Specialties has begun manufacturing operations at a new facility in China, citing growth of the country’s cyanopyridines market as the key driver for the investment.
12-Dec-2011 - in-PharmaTechnologist presents its round-up of the latest drug delivery developments, including multi-component particles, metering valve technology and crystalline salts.
12-Dec-2011 - UK drug maker AstraZeneca has bought Chinese non-branded drugmaker Guangdong BeiKang Pharma.
12-Dec-2011 - Outsourcing-Pharma presents its weekly round-up of the latest movers and shakers in the pharmaceutical industry, including news from Inviragen, Auxilium, and Icon Biosciences.
08-Dec-2011 - Drug delivery developers need more focus on the shape of the carrier, rather than the size and surface chemistry, according to a new study.
08-Dec-2011 - Mettler Toledo says its new dissolved oxygen (DO) measuring optical sensors can speed up the API production process and reduce maintenance costs.
08-Dec-2011 - Netherlands-based IMCD has bought Italian fine chemicals supplier Organotec Srl to expand its pharma actives across Europe.
07-Dec-2011 - US drug industry group PhRMA has backed FDA plans to discuss fees for biosimilars with pharmaceutical manufacturers.
07-Dec-2011 - US drugmaker Merck & Co has chosen Beijing, China as the site of its Asia R&D headquarters.
07-Dec-2011 - An injectable gel that releases drugs when triggered by an AA battery powered electric field could replace implants, say researchers.
07-Dec-2011 - Bosch Packaging Technology says melt extrusion is the answer to drug manufacturers’ active pharmaceutical ingredient (API) solubility questions.
06-Dec-2011 - Stevanato Group has pulled forward the expansion of its EZ-Fill facility in Italy by one year in a bid to dominate a bigger portion of the “rapidly expanding” ready-to-fill vials...
06-Dec-2011 - in-PharmaTechnologist presents its weekly round-up of the latest changes within the pharmaceutical job sector, including news from Takeda, Immune Design, and Pharmacyclics.
06-Dec-2011 - US developer Ampio Pharmaceuticals says new orally disintegrating tablet (ODT) tech will boost market acceptance of its premature ejaculation rug.
06-Dec-2011 - Samsung will set up a $300m biosimilars development JV with Massachusetts, US-based Biogen Idec, building on the partnership it forged with CRO Quintiles earlier this year.
05-Dec-2011 - Legal battles, patent acquisitions and R&D dominate in-pharmatechnologist.com’s round up of developments in drug delivery this week with news from MonoSol, Acacia and a US University team working on GSK’s...
05-Dec-2011 - The Ethiopian national quality control laboratory has gained ISO accreditation to improve access to safe medicines.
05-Dec-2011 - Actavis has bought Netherlands-based PharmaPack to cut its tablet packaging lead times and freight costs.
05-Dec-2011 - The US FDA has published draft guidance to help companies submit marketing applications for API-excipient co-crystals.
01-Dec-2011 - Biologics Modular is leasing its mobile production facilities to help clients make FDA regulated drugs without fixed plants.
01-Dec-2011 - Large volume production is a must for the cell therapy sector according to ATMI, which claims the latest addition to its single-use bioreactor range can help manufacturers overcome the GMP...
01-Dec-2011 - India-based Vivimed Labs is buying Uquifa for £35m ($55m) to add API capabilities in Europe and Latin America.
01-Dec-2011 - in-PharmaTechnologist presents its round-up of the latest career moves within the world of pharmaceuticals, including news from AstraZeneca, Apricus, and BioTime.
01-Dec-2011 - The drug industry's need to improve product quality while reducing production costs is driving global demand for testing technologies according to Sepha.
01-Dec-2011 - Ranbaxy has introduced generic Lipitor in the US after partnering with Teva and gaining FDA approval for manufacture at its US plant.
| « Previous month | Next month » |
BioPharm America™ 2013—6th Annual International Partnering Conference
Boston, MA, USA / Conference